Secondly, herpes simplex virus (HSV)-derived OVs have been engineered for expression of chimeric molecules to redirect immunoglobulins (Igs) towards tumor cells, which enhanced NK cell infiltration and reduced tumor burden, accompanied by stimulation of neoantigen-specific adaptive immunity in the CT26 murine colon cancer model [41]. This evidence concerns the gene CUBN and colonic neoplasm.